What's Trending

Your source for perspectives, case studies and resources on the trends shaping oncology and cardiology benefit management

  • Driving Culture Change in the Pursuit of Value: A Q&A with Cancer Care Specialists of Illinois

    Driving Culture Change in the Pursuit of Value: A Q&A with Cancer Care Specialists of Illinois

    Dr. Mark Walshauser describes the impact of high-value oncology pathways and peer collaboration on his community practice.

    Read Article
  • High-Value Clinical Pathways Help Illinois Cancer Practice Reduce Drug Spend

    High-Value Clinical Pathways Help Illinois Cancer Practice Reduce Drug Spend

    Recent journal article details how NCH and Cancer Care Specialists of Illinois teamed up to slow growth in drug spend.

    Read Article
  • ×

    First Name
    Last Name
    Company Name
    Thank you!
    Error - something went wrong!
  • New Century Health Achieves NCQA Accreditation in Utilization Management

    New Century Health Achieves NCQA Accreditation in Utilization Management

    NCH also recertified by HITRUST® for patient privacy and data security protection.

    Read Press Release
  • How Clinical Pathways Are Growing

    How Clinical Pathways Are Growing

    Increasing use of real-world evidence is one of the most exciting trends in pathway development, our CMO tells Journal of Clinical Pathways.

    Read External Article
  • Clinical Pathways Slow Drug Spending in Community Oncology

    Clinical Pathways Slow Drug Spending in Community Oncology

    Medscape delves into our work with a community oncology practice to implement high-value clinical pathways and engage providers

    Read External Article
  • Let's Go
  • A Conversation with Swedish Cancer Institute's Dr. Jeffery Ward on COVID-19's Impact on Oncology

    A Conversation with Swedish Cancer Institute's Dr. Jeffery Ward on COVID-19's Impact on Oncology

    Dr. Jeffery Ward, an Oncologist / Hematologist with Swedish Cancer Institute, discusses the initial measures to protect patients, planning for the return of deferred care, and impact of COVID-19.

    Watch Video
  • Will COVID-19 Spark a Long-Needed Conversation Around Value in Oncology?

    Will COVID-19 Spark a Long-Needed Conversation Around Value in Oncology?

    The pandemic has forced difficult trade-offs between cancer treatment and infection prevention. We also need to be willing to make hard decisions around value, our CMO writes.

    Read Article
  • Illinois Practice Shows Empowering Oncologists Can Reduce Cancer Drug Spend

    Illinois Practice Shows Empowering Oncologists Can Reduce Cancer Drug Spend

    Cancer Care Specialists of Illinois reduced drug spend by 13.5% compared to peer practices by deploying our care pathway and physician collaboration protocols

    Read Press Release
  • On-Demand Webinar: Oncology in the Wake of COVID-19: The Lasting Impact on Cancer Care

    On-Demand Webinar: Oncology in the Wake of COVID-19: The Lasting Impact on Cancer Care

    Watch this on-demand webinar to explore the future of cancer care in a post COVID-19 world.

    Watch Webinar
  • New Century Health Pathways Help Community Practice Reduce Drug Spending

    New Century Health Pathways Help Community Practice Reduce Drug Spending

    Our chief medical officer, Dr. Andrew Hertler, speaks with Journal of Clinical Pathways about our approach to high-value cancer care.

    Read External Article
  • The Impact of COVID-19 on Oncology Practices and the Delivery of Cancer Care: Insights from our Scientific Advisory Board Roundtable

    The Impact of COVID-19 on Oncology Practices and the Delivery of Cancer Care: Insights from our Scientific Advisory Board Roundtable

    Caring for a population that is highly vulnerable to COVID-19, oncology practices have had to rapidly adapt for the pandemic. Listen to key takeaways from how oncology practices are responding.

    Watch Video
  • Cancer Care During COVID-19: How Practices and Health Plans Can Navigate New Risks

    Cancer Care During COVID-19: How Practices and Health Plans Can Navigate New Risks

    Our CMO Dr. Andrew Hertler offers insights for minimizing patients' risk of COVID-19 when their cancer therapies cannot be delayed.

    Read Article
  • COVID-19 Resources for Providers and Health Plans

    COVID-19 Resources for Providers and Health Plans

    A compilation of infection prevention resources, regulatory updates and guidance for managing high-risk populations in this pandemic.

    Read Article
  • Creating a "Culture of Yes" in Prior Authorization

    Creating a "Culture of Yes" in Prior Authorization

    Prior authorization is a major source of frustration for providers and patients. Our CMO Dr. Andrew Hertler explains how a value-based approach can change that.

    Read Article
  • Let's Go
  • The Financial Burden of Breast Cancer

    The Financial Burden of Breast Cancer

    As more cancers are treated like chronic conditions, financial toxicity has become a greater problem, our CMO Dr. Andrew Hertler tells Next Avenue.

    Read External Article
  • Partnership and Pathways Drive Success in the Oncology Care Model

    Partnership and Pathways Drive Success in the Oncology Care Model

    Navigating the CMS Oncology Care Model can be complicated. Listen to oncologist Dr. Wade describe his OCM experiences and how a partnership with New Century Health positioned his practice for success.

    Watch Video
  • Lower Patient Costs Doesn’t Have to Mean Lower Profits

    Lower Patient Costs Doesn’t Have to Mean Lower Profits

    As the pace of treatment innovation threatens the financial health of both patients and oncology practices, it’s time to redefine reimbursement models to care for both financial and physical outcomes.

    Read External Article
  • The Clinical Oversight and Scientific Rigor to Design Higher-Quality Cancer Care

    The Clinical Oversight and Scientific Rigor to Design Higher-Quality Cancer Care

    New Century Health’s clinical pathways are rigorously developed and maintained by company clinicians under the oversight of an independent Scientific Advisory Board. Take a glimpse inside the board.

    Watch Video
  • Four Ways to Adapt to New Oncology Value-Based Models

    Four Ways to Adapt to New Oncology Value-Based Models

    Our CMO Dr. Andrew Hertler is quoted extensively in this Managed Healthcare Executive roundup of strategies for driving value in cancer care.

    Read External Article
  • Four Ways to Drive High-Value Drug Utilization in Oncology

    Four Ways to Drive High-Value Drug Utilization in Oncology

    Oncology drug spending in the U.S. is on an unsustainable trajectory. Explore four paths to curb costs without compromising care.

    Watch Video
  • Controlling Total Cost of Care in Oncology: Three Areas Where Health Plans Should Focus

    Controlling Total Cost of Care in Oncology: Three Areas Where Health Plans Should Focus

    Our CMO Dr. Andrew Hertler outlines value-based payment strategies and tools to help oncologists improve care across the patient journey.

    Read Article
  • loading
    Loading More...